{"transactions":[{"id":931902,"issuer":{"id":4562,"kind":"organization","name":"P3 Health Partners Inc."},"owners":[{"id":68853,"kind":"person","name":"Price Thomas Edmunds","position":1,"cik":"0001804153","reported_name":"Price Thomas Edmunds","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common\nStock","published_at":"2026-01-23T18:08:07.000Z","date":"2025-08-06","kind":"grant","planned":false,"acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") granted pursuant to the P3 Health Partners Inc. 2021 Incentive Award Plan. Each RSU represents a right to receive one share of Class A common stock. The RSUs vest upon the earlier of the Company's 2026 annual stockholder meeting and the one-year anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amended Form 4 is being filed to correct Column 5 of Table I, which inadvertently reported the number of securities beneficially owned by the Reporting Person prior to the Company's 1-for-50 reverse stock split, which became effective on April 11, 2025. This amended Form 4 is being filed solely to correct the number of securities beneficially owned by the Reporting Person following the reverse stock split."}],"balance_after":6331,"source":{"system":"sec-edgar","filing":"0001804153-26-000001","document":"wk-form4a_1769209685.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804153/000180415326000001/wk-form4a_1769209685.xml","form_type":"4/A","original_submission_date":"2025-08-08"}},{"id":1071027,"issuer":{"id":4562,"kind":"organization","name":"P3 Health Partners Inc."},"owners":[{"id":68853,"kind":"person","name":"Price Thomas Edmunds","position":1,"cik":"0001804153","reported_name":"Price Thomas Edmunds","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common\nStock","published_at":"2025-08-08T18:47:34.000Z","date":"2025-08-06","kind":"grant","planned":false,"acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") granted pursuant to the P3 Health Partners Inc. 2021 Incentive Award Plan. Each RSU represents a right to receive one share of Class A common stock. The RSUs vest in one year from date of grant."}],"balance_after":218561,"source":{"system":"sec-edgar","filing":"0001628280-25-039346","document":"wk-form4_1754693250.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804153/000162828025039346/wk-form4_1754693250.xml","form_type":"4"}},{"id":1484376,"issuer":{"id":4562,"kind":"organization","name":"P3 Health Partners Inc."},"owners":[{"id":68853,"kind":"person","name":"Price Thomas Edmunds","position":1,"cik":"0001804153","reported_name":"Price Thomas Edmunds","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-10T17:44:26.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":482640,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on the earlier of (i) June 6, 2025 and (ii) the date of the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":482640,"derivative":{"exercise_price":0.5461,"expiration_date":"2034-06-06","underlying":"Class A Common\nStock","underlying_shares":482640},"source":{"system":"sec-edgar","filing":"0001628280-24-027580","document":"wk-form4_1718055858.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804153/000162828024027580/wk-form4_1718055858.xml","form_type":"4"}},{"id":1670626,"issuer":{"id":4562,"kind":"organization","name":"P3 Health Partners Inc."},"owners":[{"id":68853,"kind":"person","name":"Price Thomas Edmunds","position":1,"cik":"0001804153","reported_name":"Price Thomas Edmunds","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common\nStock","published_at":"2024-01-25T16:18:32.000Z","date":"2023-10-23","kind":"grant","planned":false,"acquired":true,"shares":216561,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") granted pursuant to the P3 Health Partners Inc. 2021 Incentive Award Plan. Each RSU represents a right to receive one share of Class A common stock. The RSUs vest in two substantially equal installments on each of October 23, 2024 and October 23, 2025."}],"balance_after":216561,"source":{"system":"sec-edgar","filing":"0001628280-24-002240","document":"wk-form4_1706217492.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804153/000162828024002240/wk-form4_1706217492.xml","form_type":"4"}},{"id":2316225,"issuer":{"id":4562,"kind":"organization","name":"P3 Health Partners Inc."},"owners":[{"id":68853,"kind":"person","name":"Price Thomas Edmunds","position":1,"cik":"0001804153","reported_name":"Price Thomas Edmunds","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-28T17:13:23.000Z","date":"2022-03-24","kind":"grant","acquired":true,"shares":85535,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable with respect to 50% of the shares on each of March 24, 2023 and March 24, 2024."}],"balance_after":85535,"derivative":{"exercise_price":7.95,"expiration_date":"2032-03-24","underlying":"Class A Common Stock","underlying_shares":85535},"source":{"system":"sec-edgar","filing":"0001104659-22-038855","document":"tm2210604-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804153/000110465922038855/tm2210604-4_4seq1.xml","form_type":"4"}},{"id":2481641,"issuer":{"id":4562,"kind":"organization","name":"P3 Health Partners Inc."},"owners":[{"id":68853,"kind":"person","name":"Price Thomas Edmunds","position":1,"cik":"0001804153","reported_name":"Price Thomas Edmunds","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Units","published_at":"2021-12-07T21:21:32.000Z","date":"2021-12-03","kind":"grant","acquired":true,"shares":1177659,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"At the closing of the business combination pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), as described in the Issuer's definitive proxy\nstatement on Schedule 14A filed with the Securities and Exchange Commission on October 28, 2021, as supplemented, the reporting person received Common Units\nof P3 Health Group, LLC (the \"Common Units\"), a direct subsidiary of the Issuer, as consideration for the common units of P3 Health Group Holdings, LLC. In\nconnection with the receipt of Common Units, each recipient subscribed for an equal number of shares of Class V Common Stock of the Issuer for a purchase price\nequal to par value."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The Common Units are redeemable at any time by the reporting person for, at the election of the Issuer, newly-issued Class A Common Stock of the Issuer on a one-for-\none basis or a cash payment equal to the volume weighted average market price of one share of Class A Common Stock for each Common Unit redeemed. Upon\nthe redemption of any Common Units, a number of shares of Class V Common Stock of the Issuer equal to the number of Common Units that are redeemed will be\ncancelled by the Issuer for no consideration."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes 102,785 shares of Class V common stock and 102,786 Common Units of P3 Health Group, LLC being held in escrow following the business combination\ndescribed below until the resolution of a dispute among the former unitholders of P3 Health Group Holdings, LLC in accordance with the Merger Agreement (as\ndefined below). Also includes 134,359 shares of restricted Class V common stock and 134,359 restricted Common Units that vest on January 1, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the closing of the business combination pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), as described in the Issuer's definitive proxy\nstatement on Schedule 14A filed with the Securities and Exchange Commission on October 28, 2021, as supplemented, the reporting person received Common Units\nof P3 Health Group, LLC (the \"Common Units\"), a direct subsidiary of the Issuer, as consideration for the common units of P3 Health Group Holdings, LLC. In\nconnection with the receipt of Common Units, each recipient subscribed for an equal number of shares of Class V Common Stock of the Issuer for a purchase price\nequal to par value."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Common Units are redeemable at any time by the reporting person for, at the election of the Issuer, newly-issued Class A Common Stock of the Issuer on a one-for-\none basis or a cash payment equal to the volume weighted average market price of one share of Class A Common Stock for each Common Unit redeemed. Upon\nthe redemption of any Common Units, a number of shares of Class V Common Stock of the Issuer equal to the number of Common Units that are redeemed will be\ncancelled by the Issuer for no consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Common Units are redeemable at any time by the reporting person for, at the election of the Issuer, newly-issued Class A Common Stock of the Issuer on a one-for-\none basis or a cash payment equal to the volume weighted average market price of one share of Class A Common Stock for each Common Unit redeemed. Upon\nthe redemption of any Common Units, a number of shares of Class V Common Stock of the Issuer equal to the number of Common Units that are redeemed will be\ncancelled by the Issuer for no consideration."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 102,785 shares of Class V common stock and 102,786 Common Units of P3 Health Group, LLC being held in escrow following the business combination\ndescribed below until the resolution of a dispute among the former unitholders of P3 Health Group Holdings, LLC in accordance with the Merger Agreement (as\ndefined below). Also includes 134,359 shares of restricted Class V common stock and 134,359 restricted Common Units that vest on January 1, 2022."}],"balance_after":1177659,"derivative":{"underlying":"Class A Common Stock","underlying_shares":1177659},"source":{"system":"sec-edgar","filing":"0001104659-21-147364","document":"tm2134662d13_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804153/000110465921147364/tm2134662d13_4seq1.xml","form_type":"4"}},{"id":2481640,"issuer":{"id":4562,"kind":"organization","name":"P3 Health Partners Inc."},"owners":[{"id":68853,"kind":"person","name":"Price Thomas Edmunds","position":1,"cik":"0001804153","reported_name":"Price Thomas Edmunds","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class V Common Stock","published_at":"2021-12-07T21:21:32.000Z","date":"2021-12-03","kind":"grant","acquired":true,"shares":1177659,"price":117.77,"value":138692900.43,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Upon the redemption of any Common Units (as defined below), a number of shares of Class V Common Stock equal to the number of Common Units that are\nredeemed will be cancelled by the Issuer for no consideration."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes 102,785 shares of Class V common stock and 102,786 Common Units of P3 Health Group, LLC being held in escrow following the business combination\ndescribed below until the resolution of a dispute among the former unitholders of P3 Health Group Holdings, LLC in accordance with the Merger Agreement (as\ndefined below). Also includes 134,359 shares of restricted Class V common stock and 134,359 restricted Common Units that vest on January 1, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the closing of the business combination pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), as described in the Issuer's definitive proxy\nstatement on Schedule 14A filed with the Securities and Exchange Commission on October 28, 2021, as supplemented, the reporting person received Common Units\nof P3 Health Group, LLC (the \"Common Units\"), a direct subsidiary of the Issuer, as consideration for the common units of P3 Health Group Holdings, LLC. In\nconnection with the receipt of Common Units, each recipient subscribed for an equal number of shares of Class V Common Stock of the Issuer for a purchase price\nequal to par value."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 102,785 shares of Class V common stock and 102,786 Common Units of P3 Health Group, LLC being held in escrow following the business combination\ndescribed below until the resolution of a dispute among the former unitholders of P3 Health Group Holdings, LLC in accordance with the Merger Agreement (as\ndefined below). Also includes 134,359 shares of restricted Class V common stock and 134,359 restricted Common Units that vest on January 1, 2022."}],"balance_after":1177659,"source":{"system":"sec-edgar","filing":"0001104659-21-147364","document":"tm2134662d13_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804153/000110465921147364/tm2134662d13_4seq1.xml","form_type":"4"}}]}